To evaluate the effect of 2 vascular endothelial growth factor (VEGF) isoforms (121 and 165) and 2 anti-VEGF compounds (ranibizumab and pegaptanib sodium) on the permeability of human retinal pigment epithelium (RPE) cells in vitro.
Methods
The RPE permeability was assessed on ARPE19 cells grown onto inserts of polytetrafluoroethylene previously treated with ammonia gas plasma. Paracellular permeability to ions was measured by mean of transepithelial electrical resistance (TEER). Permeability to non-ionic molecules was gathered by the amount of fluorescein dextran (FD) passing across the monolayer within 2 hours.
Results
Only VEGF165 applied at the apical side of the monolayer induced a statistically significant decrease of TEER (p<0.001). No changes in TEER were observed when pegaptanib sodium or ranibizumab were apically administered together with VEGF165.
Both VEGF isoforms significantly increased permeability to 4 kDa dextran (p<0.01). Apical administration of ranibizumab or pegaptanib sodium as well as coadministration of pegaptanib sodium with VEGF121 or VEGF165 induced a statistically significant increase of permeability to 4 kDa FD.
Conclusions
Both VEGF isoforms and anti-VEGF compounds exert an effect on human RPE permeability in vitro.
KeckP.J., HauserS.D., KriviG.. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science1989; 246: 1309–12.
6.
BatesD.O., HillmanN.J., WilliamsB., NealC.R., PocockT.M.Regulation of microvascular permeability by vascular endothelial growth factors. J Anat2002; 200: 581–97.
7.
AdamisA.P., ShimaD.T., YeoK.T.. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun1993; 193: 631–8.
8.
MiuraY., KlettnerA., RoiderJ.VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: possible participation of intracellular glutathione. Invest Ophthalmol Vis Sci2010; 51: 4848–55.
9.
PengS., AdelmanR., RizzoloL.J.Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions. Invest Ophthalmol Vis Sci2010; 51: 3216–25.
10.
GhassemifarR., LaiC.M., RakoczyP.E.VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha- and mediates trans-epithelial resistance in cultured endothelial and epithelial cells. Cell Tissue Res2006; 323: 117–25.
DunnK.C., Aotaki-KeenA.E., PutkeyF.R., HjelmelandL.M.ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res1996; 62: 155–69.
14.
PuF.R., WilliamsR.L., MarkkulaT.K., HuntJ.A.Expression of leukocyte-endothelial cell adhesion molecules on monocyte adhesion to human endothelial cells on plasma treated PET and PTFE in vitro. Biomaterials2002; 23: 4705–18.
15.
CampochiaroP.A., HackettS.F., ConwayB.P.Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci1991; 32: 65–72.
16.
YasunariT., YanagiharaN., KomatsuT.. Effect of retinoic acid on proliferation and polyamine metabolism in cultured bovine retinal pigment epithelial cells. Ophthalmic Res1999; 31: 24–32.
17.
MadaraJ.L.Regulation of the movement of solutes across tight junctions. Annu Rev Physiol1998; 60: 143–59.
18.
RizzoloL.J.Polarity and the development of the outer blood-retinal barrier. Histopathology1997; 12: 1057–67.
19.
BaiL., ZhangZ., ZhangH.. HIV-1 Tat protein alter the tight junction integrity and function of retinal pigment epithelium: an in vitro study. BMC Infect Dis2008; 8: 77.
20.
AbeT., SuganoE., SaigoY., TamaiM.Interleukin-1beta and barrier function of retinal pigment epithelial cells (ARPE-19): aberrant expression of junctional complex molecules. Invest Ophthalmol Vis Sci2003; 44: 4097–104.
BaldaM.S., WhitneyJ.A., FloresC., GonzálezS., CereijidoM., MatterK.Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol1996; 134: 1031–49.
23.
ClaudeP.Morphological factors influencing transepithelial permeability: a model for the resistance of the zonula occludens. J Membr Biol1978; 39: 219–32.
24.
MatterK., BaldaM.S.Occludin and the functions of tight junctions. Int Rev Cytol1999; 186: 117–46.
25.
MiyamotoN., de KozakY., NormandN.. PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema. Ophthalmic Res2008; 40: 203–7.
26.
PitkänenL., RantaV.P., MoilanenH., UrttiA.Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci2005; 46: 641–6.
